FDA Drug Application (204591) for SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE by TEVA PHARMS USA INC

Back to FDA Applications sponsored by TEVA PHARMS USA INC

Application Number204591
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage50MG;500MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE
Active IngredientSITAGLIPTIN PHOSPHATE;METFORMIN HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient METFORMIN HYDROCHLORIDE32
List of drugs with Active Ingredient SITAGLIPTIN PHOSPHATE7


Back to FDA Applications sponsored by TEVA PHARMS USA INC